These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21649503)

  • 1. Application and interpretation of free and total drug measurements in the development of biologics.
    Ahene AB
    Bioanalysis; 2011 Jun; 3(11):1287-95. PubMed ID: 21649503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sponsor relationships, analyte stability in ligand-binding assays and critical reagent management: a bioanalytical CRO perspective.
    Lefor Bradford J
    Bioanalysis; 2015; 7(11):1337-46. PubMed ID: 26110706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in validation, risk and uncertainty assessment of bioanalytical methods.
    Rozet E; Marini RD; Ziemons E; Boulanger B; Hubert P
    J Pharm Biomed Anal; 2011 Jun; 55(4):848-58. PubMed ID: 21237607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations on ISR in multi analyte assays, QA/bioanalytical consultants and GCP by Global CRO Council for Bioanalysis (GCC).
    Sangster T; Maltas J; Struwe P; Hillier J; Boterman M; Doig M; Breda M; Garofolo F; Caturla MC; Couerbe P; Schiebl C; Pattison C; Goodwin L; Segers R; Garofolo W; Folguera L; Zimmer D; Zimmerman T; Pawula M; Tang D; Cox C; Bigogno C; Schoutsen D; de Boer T; Green R; Houghton R; Sable R; Siethoff C; Harter T; Best S;
    Bioanalysis; 2012 Jul; 4(14):1723-30. PubMed ID: 22877218
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug bioanalysis and biomarker discovery at the Commissariat à l'énergie atomique et aux énergies alternatives.
    Ezan E; Becher F; Benech H; Fenaille F; Junot C; Mabondzo A; Pruvost A
    Bioanalysis; 2010 Apr; 2(4):713-7. PubMed ID: 21083268
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioanalytical considerations in the comparability assessment of biotherapeutics.
    Lee JW; Wang YM; Moxness M; DeSilva B
    Bioanalysis; 2011 Mar; 3(6):613-22. PubMed ID: 21417731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics.
    Lee JW
    Bioanalysis; 2009 Nov; 1(8):1461-74. PubMed ID: 21083095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Waters Bioanalysis World Tour: insights into the next decade of regulated bioanalysis.
    De Vooght-Johnson R
    Bioanalysis; 2011 Feb; 3(4):369-82. PubMed ID: 21247354
    [No Abstract]   [Full Text] [Related]  

  • 10. Free versus total ligand-binding assays: points to consider in biotherapeutic drug development.
    Yang J; Quarmby V
    Bioanalysis; 2011 Jun; 3(11):1163-5. PubMed ID: 21649490
    [No Abstract]   [Full Text] [Related]  

  • 11. Research spotlight: research at the Biomedical Analysis Group of the University Utrecht, The Netherlands.
    de Jong GJ; Somsen GW
    Bioanalysis; 2010 May; 2(5):941-7. PubMed ID: 21083224
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue analysis - a powerful tool for drug discovery and development.
    Ho S
    Bioanalysis; 2012 Nov; 4(21):2545-7. PubMed ID: 23173788
    [No Abstract]   [Full Text] [Related]  

  • 13. Analytical chemistry for drug discovery and development.
    Roda A
    Anal Bioanal Chem; 2010 Sep; 398(1):27-8. PubMed ID: 20652554
    [No Abstract]   [Full Text] [Related]  

  • 14. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in developing bioanalytical assays for characterization of antibody-drug conjugates.
    Stephan JP; Kozak KR; Wong WL
    Bioanalysis; 2011 Mar; 3(6):677-700. PubMed ID: 21417735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioanalytics in medicinal chemistry: from assay development to evolutive drug design].
    Jose J
    Ann Pharm Fr; 2009 Nov; 67(6):399-407. PubMed ID: 19900603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method.
    Lecároz C; Campanero MA; Gamazo C; Blanco-Prieto MJ
    J Antimicrob Chemother; 2006 Sep; 58(3):557-63. PubMed ID: 16787953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation and sample pre-treatment in bioanalysis using monolithic phases: A review.
    Saunders KC; Ghanem A; Boon Hon W; Hilder EF; Haddad PR
    Anal Chim Acta; 2009 Oct; 652(1-2):22-31. PubMed ID: 19786168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conference report: European Bioanalysis Forum.
    Abbott RW; Brudny-Kloeppel M
    Bioanalysis; 2009 May; 1(2):273-6. PubMed ID: 21083164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.